Natera, Inc. (NTRA)

NASDAQ: NTRA · Real-Time Price · USD

244.55

+2.49 (1.03%)

At close: Dec 5, 2025, 4:00 PM EST

241.20

-3.35 (-1.37%)

After-hours: Dec 5, 2025, 7:56 PM EST

Revenue

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2014 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2014 - 2020
Insurance Carriers Revenue	1.99B	1.57B	Log In	Log In	Log In	Upgrade
Laboratory Partners Revenue	95.16M	97.21M	Log In	Log In	Log In	Upgrade
Patients Revenue	30.93M	27.88M	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.12B	1.70B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2014 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2014 - 2020
United States Revenue	2.08B	1.66B	Log In	Log In	Log In	Upgrade
Americas, excluding US Revenue	6.32M	6.62M	Log In	Log In	Log In	Upgrade
Europe, Middle East, India, Africa Revenue	23.01M	23.88M	Log In	Log In	Log In	Upgrade
Asia Pacific and Other Revenue	7.68M	8.66M	Log In	Log In	Log In	Upgrade
Revenue (Total)	2.12B	1.70B	Log In	Log In	Log In	Upgrade

Key Performance Indicators

Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2014 - 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2014 - 2020
Tests Processed	3.39M	3.06M	Log In	Log In	Log In	Upgrade
Tests Accessioned	3.34M	3.00M	Log In	Log In	Log In	Upgrade
Tests Reported	3.22M	2.93M	Log In	Log In	Log In	Upgrade
Tests Reported in Laboratory	3.17M	2.87M	Log In	Log In	Log In	Upgrade